|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 291.63 USD | +1.30% |
|
+0.69% | -16.81% |
| 12/03 | Bernstein Adjusts Price Target on Elevance Health to $384 From $409, Maintains Outperform Rating | MT |
| 12/03 | US insurers and hospitals turn to new AI for age-old battle over charges vs payments | RE |
| Capitalization | 6.44TCr 5.63TCr 5.08TCr 4.86TCr 8.84TCr 5,95300Cr 9.19TCr 61TCr 24TCr 2,84400Cr 24TCr 24TCr 10,27300Cr | P/E ratio 2026 * |
12.2x | P/E ratio 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise value | 8.58TCr 7.5TCr 6.78TCr 6.48TCr 12TCr 7,93600Cr 12TCr 81TCr 32TCr 3,79200Cr 32TCr 32TCr 13,69400Cr | EV / Sales 2026 * |
0.44x | EV / Sales 2027 * | 0.43x |
| Free-Float |
99.81% | Yield 2026 * |
2.42% | Yield 2027 * | 2.58% |
Last Transcript: Elevance Health, Inc.
| 1 day | +1.30% | ||
| 1 week | +0.69% | ||
| Current month | -8.87% | ||
| 1 month | -15.91% | ||
| 3 months | -18.78% | ||
| 6 months | -6.46% | ||
| Current year | -16.81% |
| 1 week | 274.84 |  | 295.79 |
| 1 month | 274.84 | | 352 |
| Current year | 274.84 | | 383 |
| 1 year | 273.71 | | 458.75 |
| 3 years | 273.71 | | 567.26 |
| 5 years | 273.71 | | 567.26 |
| 10 years | 114.85 | | 567.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 65 | 20/11/2017 |
Mark Kaye
DFI | Director of Finance/CFO | 47 | 01/11/2023 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
CHM | Chairman | 70 | - |
Robert Dixon
BRD | Director/Board Member | 70 | 01/07/2011 |
Lewis Hay
BRD | Director/Board Member | 70 | 01/07/2013 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -3.15% | 3.22% | 26 M€ | |
| -.--% | 2.07% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.30% | +0.69% | -30.72% | -36.41% | 6.44TCr | |
| +1.82% | -1.53% | -42.27% | -39.28% | 26TCr | |
| +0.49% | -1.63% | -14.61% | -1.82% | 7.04TCr | |
| +1.08% | -7.66% | -34.58% | -65.68% | 1.99TCr | |
| -0.35% | -21.08% | -40.80% | -45.61% | 1.69TCr | |
| +0.01% | +3.27% | -51.59% | -42.87% | 768.38Cr | |
| -0.76% | -7.86% | +7.60% | +174.92% | 347.1Cr | |
| 0.00% | -4.42% | -14.05% | -47.11% | 143.33Cr | |
| +0.51% | -1.00% | -45.90% | +113.75% | 103.88Cr | |
| -3.39% | -6.59% | -31.28% | - | 24Cr | |
| Average | +0.07% | -4.04% | -29.82% | +1.10% | 4.41TCr | |
| Weighted average by Cap. | +1.35% | -2.22% | -35.45% | -32.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19TCr 17TCr 15TCr 15TCr 27TCr 17,95600Cr 28TCr 1,83100Cr 73TCr 8,57900Cr 73TCr 71TCr 30,98400Cr | 20TCr 17TCr 16TCr 15TCr 27TCr 18,47700Cr 29TCr 1,88500Cr 75TCr 8,82800Cr 75TCr 73TCr 31,88400Cr |
| Net income | 523.48Cr 457.58Cr 413.4Cr 395.46Cr 719.28Cr 48TCr 747.69Cr 4.94TCr 1.96TCr 23TCr 1.96TCr 1.92TCr 84TCr | 562.46Cr 491.64Cr 444.17Cr 424.9Cr 772.83Cr 52TCr 803.36Cr 5.31TCr 2.1TCr 25TCr 2.11TCr 2.07TCr 90TCr |
| Net Debt | 2.14TCr 1.87TCr 1.69TCr 1.62TCr 2.95TCr 1,98300Cr 3.06TCr 20TCr 8.02TCr 95TCr 8.05TCr 7.87TCr 3,42200Cr | 2.16TCr 1.89TCr 1.7TCr 1.63TCr 2.96TCr 1,99500Cr 3.08TCr 20TCr 8.06TCr 95TCr 8.09TCr 7.92TCr 3,44200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 291.63 $ | +1.30% | 23,64,888 |
| 12/26/12 | 287.89 $ | -0.66% | 28,31,480 |
| 11/26/11 | 289.79 $ | +2.52% | 26,92,761 |
| 10/26/10 | 282.68 $ | +0.69% | 29,14,304 |
| 09/26/09 | 280.74 $ | -3.07% | 27,58,571 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition